Detalhe da pesquisa
1.
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat.
Pulm Circ
; 12(2): e12055, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35514769
2.
Health-related quality of life and hospitalizations in chronic thromboembolic pulmonary hypertension versus idiopathic pulmonary arterial hypertension: an analysis from the Pulmonary Hypertension Association Registry (PHAR).
Pulm Circ
; 11(4): 20458940211053196, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34671455